Robert J. Decker - 30 Aug 2024 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
VP Corporate Controller
Signature
/s/ Laura H. McFalls, as attorney-in-fact for Robert J. Decker
Issuer symbol
JNJ
Transactions as of
30 Aug 2024
Net transactions value
-$366,275
Form type
4
Filing time
03 Sep 2024, 16:48:12 UTC
Previous filing
20 Feb 2024
Next filing
12 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $563,838 +5,635 +30% $100.06 24,608 30 Aug 2024 Direct
transaction JNJ Common Stock Sale $930,113 -5,635 -23% $165.06 18,973 30 Aug 2024 Direct
holding JNJ Common Stock 614 30 Aug 2024 By 401k F1
holding JNJ Common Stock 134 30 Aug 2024 By ESOP F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -5,635 -100% $0.000000 0 30 Aug 2024 Common Stock 5,635 $100.06 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/30/2024).
F2 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/30/2024).